FAC Explorer

Ascencia

Audits
4
Findings
40
Total Expended
$6.60M
Latest Accepted
2026-03-30
Location: Glendale, CA
UEI: U61XJCTCWKG8 EIN: 204233822

SAM.gov Exclusion Status:

Audits by Year

  • 2022 1
  • 2023 1
  • 2024 1
  • 2025 1

Top Programs

By expenditures

Loading recommendations...

Contacts

Name Title Type
Laura Duncan Executive Director Auditee
Frank Saito Partner Auditee
No contacts on file

Recent Audits

ID Year Date Accepted Auditor Spend
396638 2025 2026-03-30 LEE SPERLING HISAMUNE / ACCOUNTANCY CORPORATION $1.56M
343553 2024 2025-02-24 Lee Sperling Hisamune Accountancy Corporation $1.51M
300306 2023 2024-03-29 Lee Sperling Hisamune/accountancy Corporation $1.69M
44175 2022 2023-03-30 Lee Sperking Hisamune/a C $1.84M

Audit Findings

Audit Year Accepted Finding Ref Severity Repeat Requirement
300306 2023 2024-03-29 965762 2023-002 Significant Deficiency - P
300306 2023 2024-03-29 965761 2023-002 Significant Deficiency - P
300306 2023 2024-03-29 965760 2023-002 Significant Deficiency - P
300306 2023 2024-03-29 965759 2023-002 Significant Deficiency - P
300306 2023 2024-03-29 965758 2023-002 Significant Deficiency - P
300306 2023 2024-03-29 965757 2023-002 Significant Deficiency - P
300306 2023 2024-03-29 965756 2023-002 Significant Deficiency - P
300306 2023 2024-03-29 965755 2023-002 Significant Deficiency - P
300306 2023 2024-03-29 965754 2023-002 Significant Deficiency - P
300306 2023 2024-03-29 965753 2023-002 Significant Deficiency - P
300306 2023 2024-03-29 965752 2023-001 Significant Deficiency - P
300306 2023 2024-03-29 965751 2023-001 Significant Deficiency - P
300306 2023 2024-03-29 965750 2023-001 Significant Deficiency - P
300306 2023 2024-03-29 965749 2023-001 Significant Deficiency - P
300306 2023 2024-03-29 965748 2023-001 Significant Deficiency - P
300306 2023 2024-03-29 965747 2023-001 Significant Deficiency - P
300306 2023 2024-03-29 965746 2023-001 Significant Deficiency - P
300306 2023 2024-03-29 965745 2023-001 Significant Deficiency - P
300306 2023 2024-03-29 965744 2023-001 Significant Deficiency - P
300306 2023 2024-03-29 965743 2023-001 Significant Deficiency - P
300306 2023 2024-03-29 389320 2023-002 Significant Deficiency - P
300306 2023 2024-03-29 389319 2023-002 Significant Deficiency - P
300306 2023 2024-03-29 389318 2023-002 Significant Deficiency - P
300306 2023 2024-03-29 389317 2023-002 Significant Deficiency - P
300306 2023 2024-03-29 389316 2023-002 Significant Deficiency - P
300306 2023 2024-03-29 389315 2023-002 Significant Deficiency - P
300306 2023 2024-03-29 389314 2023-002 Significant Deficiency - P
300306 2023 2024-03-29 389313 2023-002 Significant Deficiency - P
300306 2023 2024-03-29 389312 2023-002 Significant Deficiency - P
300306 2023 2024-03-29 389311 2023-002 Significant Deficiency - P
300306 2023 2024-03-29 389310 2023-001 Significant Deficiency - P
300306 2023 2024-03-29 389309 2023-001 Significant Deficiency - P
300306 2023 2024-03-29 389308 2023-001 Significant Deficiency - P
300306 2023 2024-03-29 389307 2023-001 Significant Deficiency - P
300306 2023 2024-03-29 389306 2023-001 Significant Deficiency - P
300306 2023 2024-03-29 389305 2023-001 Significant Deficiency - P
300306 2023 2024-03-29 389304 2023-001 Significant Deficiency - P
300306 2023 2024-03-29 389303 2023-001 Significant Deficiency - P
300306 2023 2024-03-29 389302 2023-001 Significant Deficiency - P
300306 2023 2024-03-29 389301 2023-001 Significant Deficiency - P